Palliative Care Clinical Trial
Official title:
Sodium Oxybate Versus Midazolam for Comfort Sedation
The study aims at deepen the proof level of sodium oxybate use for comfort sedation at the end of life in a palliative care unit by comparing it to midazolam in a prospective randomized study with blinded efficacy evaluation. The study will be carried out for a period of 24 months with a recruitment objective of 22 patients with refractory suffering and with a short-term prognosis.
In certain cases, terminally-ill patients may show persistent symptoms despite numerous efforts to find a comfort treatment without causing impaired consciousness. In these cases and after a collegial discussion, sedation may be offered. Midazolam is then the most typically used sedative agent. However, it has limitations: frequent awakenings, tolerance and major respiratory depression. Furthermore, the use of midazolam as a "gold standard" in palliative sedation at the end of life falls under expert consensus without a high level of evidence. Sodium oxybate (GammaOH®), is an ancient molecule used in anesthesia and other medical fields. It appears to be an attractive alternative to midazolam. Study hypothesis is as follows: deep sedation induced by sodium oxybate (RASS: -4 or -5) is more constant and sustainable than by using midazolam which can cause fluctuating effects and requires frequent dosage adjustments. The single-blind clinical trial aims at comparing the possibility to obtain constant deep sedation using midazolam or sodium oxybate. Before the induction, the patient is not aware of the medication used. The medical team must be aware of it because the two administration procedures are too different. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04673760 -
The PROAKTIV Study
|
N/A | |
Completed |
NCT03520023 -
Critical Care and Palliative Care Medicine Together in the ICU
|
N/A | |
Completed |
NCT01990742 -
Improving Palliative Care Through Teamwork
|
N/A | |
Not yet recruiting |
NCT05434208 -
Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL)
|
N/A | |
Not yet recruiting |
NCT03267706 -
Introducing the Palliative Care Comprehensive Tool in Family Medicine
|
N/A | |
Completed |
NCT02845817 -
Requests for Euthanasia and Assisted Suicide
|
N/A | |
Recruiting |
NCT02778347 -
Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs
|
N/A | |
Completed |
NCT01933789 -
Improving Communication About Serious Illness
|
N/A | |
Completed |
NCT01934413 -
Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study
|
N/A | |
Recruiting |
NCT01170000 -
Timely End-of-Life Communication to Parents of Children With Brain Tumors
|
N/A | |
Recruiting |
NCT04052074 -
Complementary Therapy in Home Palliative Care Patients and Their Caregivers
|
N/A | |
Recruiting |
NCT05935540 -
ACP-Family Programme for Palliative Care Patients and Their Family Member
|
N/A | |
Active, not recruiting |
NCT02689375 -
A Prospective, Open Label, Pilot Study of Patient OutcoMes Following Successful TriAl of High Frequency SpInal CorD Stimulation at 10kHz (HF10™) Leading to Permanent Implant Compared to Trial Failure and Standard CarE for the TreatmeNt of Persistent Low BACK Pain of Neuropathic Origin
|
N/A | |
Recruiting |
NCT05520281 -
Short-term Psychodynamic Psychotherapy in Serious Physical Illness
|
N/A | |
Completed |
NCT06140004 -
Home-Based Palliative Care Impact on Providers
|
||
Completed |
NCT04333719 -
Prevalence of Deep Sedation in Terminal Palliative Phase
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|
||
Completed |
NCT06211816 -
Efficacy of End-of-life Communication Strategies on Nurses in the Intensive Care Unit
|
N/A | |
Completed |
NCT04857060 -
Palliative Care Educator
|
N/A | |
Completed |
NCT04491110 -
Intervention to Improve Quality of Sleep of Palliative Patient Carers in the Community: Clinical Trial
|
N/A |